Sodexo Ventures
Sodexo Ventures is the investment arm of Sodexo, a global leader in services that improve Quality of Life, based in Issy-les-Moulineaux, France. While the year of establishment for Sodexo Ventures isn't specified, the parent company, Sodexo, was founded in 1966 by Pierre Bellon. This venture capital division seeks to enhance innovation by investing in start-ups that align with its mission of improving daily life. Sodexo Ventures leverages access to the broader Sodexo ecosystem to benefit its portfolio companies.
Sodexo Ventures primarily invests in sectors related to its core business, including food and beverage, hospitality, and facilities management, with a focus on innovations in customer experience and operational efficiency. Investment sizes are typically in the early to mid-range for strategic growth, but exact figures are not available. They invest in companies globally, aligning with Sodexo's international operations. They maintain a focus on long-term partnerships rather than providing specific exit strategies.
Notable investments include companies like Lunchr - meal voucher platform, and Wynd - a unified retail platform that enhances customer experience and sales. These investments highlight Sodexo Ventures’ commitment to supporting innovations that align with Sodexo’s service-oriented goals.
SOFAZ (State Oil Fund of the Republic of Azerbaijan)
Azerbaijan is well-known worldwide as an ancient oil country. From the late 19th to the early 20th century, Baku has transformed into one of the biggest oil centres in the world.
After Azerbaijan gained its independence, oil played a crucial role in the country’s development. At the time, the country suffered from military aggression and faced a multitude of different risks. To rebuild the country, the national leader Heydar Aliyev developed a long-term oil strategy. The three pillars of this strategy include:
the attraction of foreign investments and expertise
establishment of multi-optional export routes
efficient and transparent management of accumulated revenues
On September 20, 1994, Azerbaijan signed the Azeri-Chirag-Gunashli Production Sharing Agreement (PSA) with leading international oil companies. Dubbed the “Contract of the Century,” this agreement spurred the signing of new oil contracts, which generated substantial revenues for the country. These developments urged the need to establish an entity whereby assets could be accumulated and efficiently managed. Ilham Aliyev, the vice-president of SOCAR back then, initiated the realization of this idea. As proposed by Ilham Aliyev, the experiences of similar sovereign wealth funds abroad were thoroughly evaluated.
Consequently, the national leader Heydar Aliyev signed a Decree to establish the State Oil Fund of the Republic of Azerbaijan (SOFAZ) on December 29, 1999.
SOFAZ is an extra-budgetary fund and functions as a legal entity separate from the government or central bank. SOFAZ safeguards and prudently manages energy-related earnings for present and future generations. One of the key principles of SOFAZ is transparency. Throughout this period, the Fund has developed institutionally and became an internationally recognized asset management organization.
Sofia Angels Ventures
Sofia Angels Ventures is a venture capital fund based in Bulgaria with a focus on technology startups. It is backed by the European Investment Fund, along with support from angels, family offices, and other private investors. The fund consists of a team of experienced angel investors, entrepreneurs, and executives who transitioned into the venture capital space, indicating a wealth of hands-on experience in the industry.
The firm primarily invests in technology startups at pre-seed and seed stages with a geographical focus on Bulgaria, as well as Southeast Europe (SEE), Central and Eastern Europe (CEE), and has ambitions for a wider European and global reach. The current fund size is €13 million, reflecting their capacity to support early-stage ventures. They focus on entering at initial stages and growing with their investments over time.
Notable portfolio companies include Almacena - specializing in agri supply chain tech and finance solutions; inHeart Medical - offering software for 3D modeling in cardiac procedures; Frisbo - a European eCommerce network leader; Addit.tech - introducing the Device-as-a-Service model; and Ethermind - creating AI personas for enhanced training engagement.
Sofia Fund
Sofia Fund is an angel group based in Minnesota, founded in 1998. The firm is led by Cathy Connett, Lisa Crump, Joy Lindsay, and Dee Thibodeau, who bring extensive experience as operators and investors. Sofia Fund is distinguished by its focus on investing in women-led growth companies, leveraging technology to solve real-world problems. The team is committed to fostering economic value through gender-diverse teams and scalable business models.
The firm primarily invests in sectors such as information technology, enterprise solutions, and health and wellness, with a focus on B2B markets within the United States. Typical investment sizes range from $100,000 to $500,000, targeting rounds of $500,000 to $2 million. Sofia Fund seeks companies with proprietary positions in large, growing markets, aiming for exits within 3 to 5 years. The firm has invested over $10 million in more than 50 companies.
Notable investments include Dispatch Goods - sustainable packaging solutions, Strategikon Pharma - clinical trial management software, StormSensor - environmental monitoring systems, Tilt - business productivity software, and Abilitech Medical - therapeutic devices. These investments reflect Sofia Fund's commitment to supporting innovative, technology-driven companies.
Sofimac Innovation
Sofimac Innovation is a venture capital firm that has made its mark by focusing on the development of innovative companies. Headquartered in France, the firm has built a team with a strong background in capital investment, fostering a culture that deeply understands the technical and market dynamics of numerous sectors. Its composition comprises experienced investors who collaborate closely with entrepreneurs to guide them through strategic growth stages.
The firm invests primarily in industries such as biotechnology, digital technology, and industrial innovations, aiming to support startups from the seed stage to later stages of development. Sofimac Innovation typically provides funding ranging between $1-5 million depending on the maturity and needs of the business. The firm has managed multiple funds, backed by a diverse range of limited partners, and is recognized for its commitment to nurturing high-potential startups.
Notable investments in Sofimac Innovation's portfolio include companies like Pharnext - a biopharmaceutical firm, Aryballe - a digital olfaction company, and Diabeloop - a health tech company. These investments exemplify Sofimac's focus on transformative technologies across diverse sectors, underlining their strategic intent to drive innovation at scale.
Sofina
Sofina is a Belgium-based investment company listed on the Brussels stock exchange and a supportive partner of entrepreneurs and families managing growing companies. Founded more than 120 years ago as an engineering conglomerate, Sofina is now a listed investment company with equity holdings in Europe, the United States and Asia, and across many sectors with a particular focus on consumer and retail, digital transformation, education and healthcare
Sofindev Management NV
Sofindev was founded by Sofina and Colruyt in 1991 and is therefore one of the oldest independent private equity funds in Belgium. Since 1991, the Sofindev shareholders have invested more than 150 MEUR through 3 funds: Sofindev I, Sofindev II (°2002) and Sofindev III (°2006) in more than 40 Belgian companies. In May 2015, a new Sofindev fund, Sofindev IV, has been created.
<br />
<br />
Sofina and Colruyt, the founders of Sofindev, have been the cornerstone investors in Sofindev funds for more than 25 years. Both companies are listed on Euronext Brussels. Sofina is a Belgian listed financial holding company with the Boël family as reference shareholder. Colruyt Group is one of the largest food retail groups in Belgium, with the Colruyt family as reference shareholder. The Colruyt family is also a direct investor in Sofindev funds through the family investment company Korys.
Sofinnova
Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, France, the firm brings together 12 highly experienced investment professionals from all over Europe, the US and China. The firm focuses on paradigm shifting technologies alongside visionary entrepreneurs. Sofinnova Partners seeks to invest as a founding and lead investor in start-ups and corporate spin-offs, and has backed nearly 500 companies over more than 40 years, creating market leaders around the globe.
Sofinnova Investments
Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A.
Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and Europe with approximately $3.3B in assets under management and committed capital as of 6/30/2024.
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.
Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management. For more information, please visit: www.sofinnovapartners.com